Ester Martín-Villar

Universidad Francisco de Vitoria — Spain

Medicine · Health Sciences

17h-index1.9kcitations38works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphatic System and Diseases(13), Skin and Cellular Biology Research(7), Cancer Cells and Metastasis(4), Advanced Breast Cancer Therapies(4), Breast Cancer Treatment Studies(3)

Publications38 total

Corrigendum to: Ca2+/calmodulin-driven functions mediated by extracellular vesicles: a physiopathological perspective
Cell Calcium·2026Open Access
Ca2+/calmodulin-driven functions mediated by extracellular vesicles: a physiopathological perspective
Cell Calcium·2025
Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy
Frontiers in Oncology·2025Open Access
The clinical laboratory: a decision maker hub
Clinical Chemistry and Laboratory Medicine (CCLM)·2021· 17 cited
Cinco ‘tips’ para aplicar la transparencia en la gestión de las entidades de la Iglesia
Vida Nueva·2021
Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients
European Journal of Cancer·2020· 23 citedOpen Access
Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
Cells·2020· 17 citedOpen Access
Prediction of early progression (EP) to CDKIs first line treatment in ER+/HER2- metastatic breast cancer (MBC) using machine learning.
Journal of Clinical Oncology·2020
CDK4/6 inhibitors and hormone therapy in hormone receptor-positive advanced breast cancer: Real-world data and intrinsic subtypes defined by PAM50.
Journal of Clinical Oncology·2020
Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer
International Journal of Molecular Sciences·2019· 28 citedOpen Access
Podoplanin in Inflammation and Cancer
International Journal of Molecular Sciences·2019· 226 citedOpen Access
Reduced expression of the murine HLA-G homolog Qa-2 is associated with malignancy, epithelial-mesenchymal transition and stemness in breast cancer cells
Scientific Reports·2017· 12 citedOpen Access
Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase
Scientific Reports·2016· 42 citedOpen Access
Podoplanin is a component of extracellular vesicles that reprograms cell-derived exosomal proteins and modulates lymphatic vessel formation
Oncotarget·2016· 76 citedOpen Access
Prosigna (PAM50) to predict response to neoadjuvant chemotherapy (NAC) in HR+/HER2- early breast cancer (EBC) patients.
Journal of Clinical Oncology·2015· 3 cited
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
JNCI Journal of the National Cancer Institute·2015· 117 citedOpen Access
PO-092: Phase II study of TPF and cetuximab+RT in locally advanced laryngeal/hypopharyngeal carcinoma
Radiotherapy and Oncology·2015
New Insights into the Role of Podoplanin in Epithelial–Mesenchymal Transition
International review of cell and molecular biology·2015· 68 citedOpen Access
Soluble endoglin antagonizes Met signaling in spindle carcinoma cells
Carcinogenesis·2014· 10 citedOpen Access
Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability
Oncogene·2014· 78 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Miguel Quintanilla(18), Jaime Renart(11), María M. Yurrita(8), Beatriz Fernández‐Muñoz(5), Nuria Ribelles(5), Alfonso Sánchez‐Muñoz(5), Emilio Alba(5), Diego Megı́as(4), Eduardo Pérez-Gómez(4), Patricia Carrasco-Ramírez(4), F. Carabantes(4), María Emilia Domínguez-Recio(4), Ana Godoy-Ortíz(4), Lucía Montero-Montero(3), Gareth E. Jones(3), José M. Jerez(3), Bella Pajares(3), Gaelle del Castillo(3), Francisco G. Scholl(2), Maddy Parsons(2)